Fundraising FoxAlpha Wave Global — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
Apnimed develops investigational oral pharmaceutical therapies for obstructive sleep apnea (OSA), including its lead clinical candidate AD109, a neuromuscular approach intended to treat undertreated and untreated OSA patients.
BiotechDigital HealthHealthtechCambridge, US
Lawrence G. Miller(Executive Officer, Director)inDennis Molnar(Executive Officer)inBarry Wohl(Chief Business Officer)inKetan Mehta(Head of Product and Engineering, Connected Wearables)Ron Farquhar(Director)Gerald Chan(Director)
Co-investorsHEALTHCARE ROYALTY PARTNERSMorningside GroupSectoral Asset Management
Nxtra operates a network of hyperscale and edge data centers across India, offering colocation, build-to-suit, interconnect, migration, and 24x7 support services.
Cloud ComputingData & InfrastructureEnterprise SoftwareGreenwich, US
Ihsan Essaid(Executive Officer)inBrad Jacobs(Executive Officer, Director)inValeri Liborski(Executive Officer)inChris Signorello(Chief Legal Officer)in
BoardJared Kushner(Director)Jason Aiken(Director)
Co-investorsApollo Asset ManagementApolloTemasek
Anthropic is an AI safety research company that builds reliable, interpretable, and steerable AI systems.
AI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwareSan Francisco, US
Dario Amodei(Founder)inDaniela Amodei(Founder)inTom Brown(Founder)inJack Clark(Founder)inJared Kaplan(Founder)inChris Olah(Founder)in
Co-investors3Comma Capital7BC Venture Capital7GC & CoA.Capital VenturesAccelAdvent International+168 more
EVEN is a direct-to-fan platform where music artists sell releases to fans and receive daily payouts.
Mag R.(Founder)inJon Schlossberg(Founder)Mag Rodriguez(Founder)
Co-investors10SQ Capital (TenSquared)37 AngelsCSA Partners LLCTundra AngelsVC 4148VC+7 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.